Guardant Health (GH) Tops Q2 EPS by 21c

Guardant Health (NASDAQ: GH) reported Q2 EPS of ($1.00), $0.21 better than the analyst estimate of ($1.21). Revenue for the quarter came in at $109.1 million versus the consensus estimate of $105.08 million.

GUIDANCE:

Guardant Health sees FY2022 revenue of $460-470 million, versus the consensus of $465.3 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• Pfizer lung cancer drug misses survival goal in Phase 3 trial